Announcements

Peter Barton Hutt, Angels for Change, and City of Hope to Receive 2026 Innovations in Regulatory Science & Policy Awards
The Reagan-Udall Foundation for the FDA will recognize the late Peter Barton Hutt, Angels for Change, and City of Hope at its 10th annual Innovations in Regulatory Science & Policy Awards on December 8, 2026. The awards honor contributions to…
Read More
The Foundation’s Role in Advancing Medical Product Development in the United States
Read More
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Maintaining America's Leadership in Biomedical Innovation: FDA's Role in Advancing U.S. Drug Development Written Testimony
Read More
More Announcements

Coverage

Palvella Therapeutics Q3 2026 Earnings Call Transcript
Palvella Therapeutics recently attended the FDA’s public meeting on the initiative held on October 28th in partnership with the Reagan-Udall Foundation.
Read More
Delivering Answers and Hope for Rare Disease Families
Last month, the FDA took a bold leap forward by launching the Rare Disease Framework Initiative with a public meeting that included feedback from 75 members of the rare disease community; I was honored to participate in this meeting, and we will be…
Read More
The Flexibility Papers No. 3: Old Drugs, New Possibilities – Repurposing as Part of the Rare Disease Framework
On August 5, 2026, FDA and the Reagan-Udall Foundation for the FDA convened a public meeting on drug repurposing.
Read More
More Coverage